Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding
Endocrine Oncology · 2021
DOI: 10.1530/eo-21-0031 ↗Kurz gefasst
Fallbericht in der Zeitschrift Endocrine Oncology, 2021. Verfasst von Nada Younes und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Needle tract seeding is a potential, albeit rare, complication following transcutaneous biopsies, leading to the seeding of tumor cells along the path of the needle. Biopsies of adrenal masses are not routinely recommended and are only indicated, after exclusion of pheochromocytoma, when an adrenal metastasis of a primary extra-adrenal cancer is suspected or when pathological confirmation of inoperable adrenocortical cancer (ACC) may impact treatment. Despite guideline recommendations to avoid primary adrenal biopsy, very few needle tract seeding cases have been reported and none were in the context of an ACC. We report the occurrence of needle tract seeding in a patient following adrenal transcutaneous biopsy leading to ACC abdominal wall recurrence. Learning points Needle tract seeding is a rare complication of transcutaneous biopsy. It may increase morbidity and impact overall survival. It has yet to be documented in adrenocortical carcinoma (ACC). Adrenal masses can be accurately evaluated for malignancy using a combination of conventional and metabolic imaging, such as CT and fluorodeoxyglucose-PET, obviating the need for biopsies. Adrenal mass biopsy is not indicated in ACC unless advanced ACC is diagnosed, and a pathological confirmation would impact management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Endocrinology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
- Division of Hematology and Medical Oncology, Department of Medicine, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
- Division of Urology, Department of Surgery, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
- Department of Radiology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
- Department of Pathology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
- Division of Radiation Oncology, and Research Center, Centre hospitalier de l'Université de Montréal (CHUM), Montréal, Québec, Canada.
Zitieren
APA
Younes, N., Bourdeau, I., Olney, H., Perrotte, P., Prosmanne, O., Latour, M., Roberge, D., & Lacroix, A. (2021). Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding. Endocrine Oncology. https://doi.org/10.1530/eo-21-0031
Vancouver
Younes N, Bourdeau I, Olney H, Perrotte P, Prosmanne O, Latour M, et al. Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding. Endocrine Oncology. 2021. doi:10.1530/eo-21-0031
BibTeX
@article{Younes2021,
author = {Younes, Nada and Bourdeau, Isabelle and Olney, Harold and Perrotte, Paul and Prosmanne, Odile and Latour, Mathieu and Roberge, David and Lacroix, André},
title = {Adrenocortical cancer recurrence following initial transcutaneous biopsy: a rare demonstration of needle tract seeding},
journal = {Endocrine Oncology},
year = {2021},
doi = {10.1530/eo-21-0031}
}
EUVIMED